A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT01482221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effect and safety of AZD6765 in patients with major depressive disorder who exhibit inadequate response to antidepressants. AZD6765 is a channel blocker of the N-methyl-D-aspartate (NMDA) class of glutamate receptors.
Study identification
- NCT ID
- NCT01482221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 542 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2011 (Actual)
- Primary completion
- Aug 26, 2013 (Actual)
- Completion
- Aug 26, 2013 (Actual)
- Last update posted
- Apr 11, 2017
2011 – 2013
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Chino | California | — | — |
| Research Site | Lond Beach | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Stanford | California | — | — |
| Research Site | New Heaven | Connecticut | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Gainsville | Florida | — | — |
| Research Site | Lake City | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | St. Petersburg | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Decatur | Georgia | — | — |
| Research Site | Hoffman Estates | Illinois | — | — |
| Research Site | Joliet | Illinois | — | — |
| Research Site | Skokie | Illinois | — | — |
| Research Site | Lake Charles | Louisiana | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Willingboro | New Jersey | — | — |
| Research Site | Mount Kisco | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01482221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2017 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01482221 live on ClinicalTrials.gov.